|
|||||
|
|
Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial |
|
| Authors: | Mark J. Sculpher Greta Lozano-Ortega Jennifer Sambrook Stephen Palmer Orges Ormanidhi Ameet Bakhai Marcus Flather P. Gabriel Steg Shamir R. Mehta William Weintraub |
| Affiliation: | a Centre for Health Economics, University of York, York, United Kingdom b Oxford Outcomes Ltd, Oxford, United Kingdom c Oxford Outcomes Ltd, Vancouver, British Columbia, Canada d AMORE studies group, London, United Kingdom e Barnet & Chase Farm NHS Trust, Barnet, United Kingdom f Clinical Trials and Evaluation Unit, Royal Brompton Hospital, London, United Kingdom g INSERM U-698 and Université Paris VII - Denis Diderot, Hôpital Bichat-Claude Bernard, Paris, France h Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada i Christiana Care Health System, Newark, DE |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |